110 related articles for article (PubMed ID: 11185329)
1. The impact of automatic prescriptions on reducing low-density lipoprotein cholesterol levels.
Siskind A; Johnson M; Qureshi A; Solow B; Chesebro D; Oldham N
Eff Clin Pract; 2000; 3(5):240-6. PubMed ID: 11185329
[TBL] [Abstract][Full Text] [Related]
2. Achieving cholesterol target in a managed care organization (ACTION) trial.
Straka RJ; Taheri R; Cooper SL; Smith JC
Pharmacotherapy; 2005 Mar; 25(3):360-71. PubMed ID: 15843283
[TBL] [Abstract][Full Text] [Related]
3. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
Harley CR; Gandhi S; Blasetto J; Heien H; Sasane R; Nelson SP
Am J Geriatr Pharmacother; 2007 Sep; 5(3):185-94. PubMed ID: 17996658
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of the addition of ezetimibe to ongoing statin therapy in modifying lipid profiles and attaining low-density lipoprotein cholesterol goals in older and elderly patients: subanalyses of data from a randomized, double-blind, placebo-controlled trial.
Pearson T; Denke M; McBride P; Battisti WP; Brady WE; Palmisano J
Am J Geriatr Pharmacother; 2005 Dec; 3(4):218-28. PubMed ID: 16503317
[TBL] [Abstract][Full Text] [Related]
5. Effect of rosuvastatin compared with other statins on lipid levels and National Cholesterol Education Program goal attainment for low-density lipoprotein cholesterol in a usual care setting.
Bullano MF; Wertz DA; Yang GW; Kamat S; Borok GM; Gandhi S; McDonough KL; Willey VJ
Pharmacotherapy; 2006 Apr; 26(4):469-78. PubMed ID: 16553504
[TBL] [Abstract][Full Text] [Related]
6. Clinical trial of an educational intervention to achieve recommended cholesterol levels in patients with coronary artery disease.
Lichtman JH; Amatruda J; Yaari S; Cheng S; Smith GL; Mattera JA; Roumanis SA; Wang Y; Radford MJ; Krumholz HM
Am Heart J; 2004 Mar; 147(3):522-8. PubMed ID: 14999204
[TBL] [Abstract][Full Text] [Related]
7. Overcoming inertia: improvement in achieving target low-density lipoprotein cholesterol.
Goldberg KC; Melnyk SD; Simel DL
Am J Manag Care; 2007 Sep; 13(9):530-4. PubMed ID: 17803367
[TBL] [Abstract][Full Text] [Related]
8. Low-density lipoprotein cholesterol goal attainment among high-risk patients: Does a combined intervention targeting patients and providers work?
Afonso NM; Nassif G; Aranha AN; Delor B; Cardozo LJ
Am J Manag Care; 2006 Oct; 12(10):589-94. PubMed ID: 17026413
[TBL] [Abstract][Full Text] [Related]
9. Reducing low-density lipoprotein cholesterol levels in an ambulatory care system. Results of a multidisciplinary collaborative practice lipid clinic compared with traditional physician-based care.
Shaffer J; Wexler LF
Arch Intern Med; 1995 Nov; 155(21):2330-5. PubMed ID: 7487258
[TBL] [Abstract][Full Text] [Related]
10. Lowering LDL cholesterol in adults: a prospective, community-based practice initiative.
Coodley GO; Jorgensen M; Kirschenbaum J; Sparks C; Zeigler L; Albertson BD
Am J Med; 2008 Jul; 121(7):604-10. PubMed ID: 18538295
[TBL] [Abstract][Full Text] [Related]
11. Results of the National Cholesterol Education (NCEP) Program Evaluation ProjecT Utilizing Novel E-Technology (NEPTUNE) II survey and implications for treatment under the recent NCEP Writing Group recommendations.
Davidson MH; Maki KC; Pearson TA; Pasternak RC; Deedwania PC; McKenney JM; Fonarow GC; Maron DJ; Ansell BJ; Clark LT; Ballantyne CM
Am J Cardiol; 2005 Aug; 96(4):556-63. PubMed ID: 16098311
[TBL] [Abstract][Full Text] [Related]
12. Postmarketing analysis of lovastatin use in the VA Northern California System of Clinics: a retrospective, computer-based study.
Swislocki AL; Lin K; Cogburn D; Fann KY; Khuu DT; Noth RH
Am J Manag Care; 1997 Oct; 3(10):1537-45. PubMed ID: 10178460
[TBL] [Abstract][Full Text] [Related]
13. Cardiovascular risk assessment and treatment to target low density lipoprotein levels in hospitalized ischemic heart disease patients: results of the HOLEM study.
Harats D; Leibovitz E; Maislos M; Wolfovitz E; Chajek-Shaul T; Leitersdorf E; Gavish D; Gerber Y; Goldbourt U;
Isr Med Assoc J; 2005 Jun; 7(6):355-9. PubMed ID: 15984375
[TBL] [Abstract][Full Text] [Related]
14. A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance.
Sasaki J; Ikeda Y; Kuribayashi T; Kajiwara K; Biro S; Yamamoto K; Ageta M; Kobori S; Saikawa T; Otonari T; Kono S
Clin Ther; 2008 Jun; 30(6):1089-101. PubMed ID: 18640465
[TBL] [Abstract][Full Text] [Related]
15. Predictors of uncontrolled hyperlipidaemia in high-risk ambulatory patients in primary care.
Hildemann S; Karmann B; Pittrow D; Barho C; Darius H; Bode C
Curr Med Res Opin; 2008 Jun; 24(6):1659-68. PubMed ID: 18457604
[TBL] [Abstract][Full Text] [Related]
16. The effect of pharmacist intervention and patient education on lipid-lowering medication compliance and plasma cholesterol levels.
Ali F; Laurin MY; Larivière C; Tremblay D; Cloutier D
Can J Clin Pharmacol; 2003; 10(3):101-6. PubMed ID: 14506507
[TBL] [Abstract][Full Text] [Related]
17. Reaching goal in hypercholesterolaemia: dual inhibition of cholesterol synthesis and absorption with simvastatin plus ezetimibe.
Daskalopoulou SS; Mikhailidis DP
Curr Med Res Opin; 2006 Mar; 22(3):511-28. PubMed ID: 16574035
[TBL] [Abstract][Full Text] [Related]
18. Achieving lipoprotein goals in patients at high risk with severe hypercholesterolemia: efficacy and safety of ezetimibe co-administered with atorvastatin.
Stein E; Stender S; Mata P; Sager P; Ponsonnet D; Melani L; Lipka L; Suresh R; Maccubbin D; Veltri E;
Am Heart J; 2004 Sep; 148(3):447-55. PubMed ID: 15389231
[TBL] [Abstract][Full Text] [Related]
19. Dyslipidemia control in indigent patients receiving medication assistance compared with insured patients.
Marrs JC; Saseen JJ
Pharmacotherapy; 2008 May; 28(5):562-9. PubMed ID: 18447654
[TBL] [Abstract][Full Text] [Related]
20. Do disease management programs for patients with coronary heart disease make a difference? Experiences of nine practices.
Walsh MN; Simpson RJ; Wan GJ; Weiss TW; Alexander CM; Markson LE; Berger ML; Pearson TA
Am J Manag Care; 2002 Nov; 8(11):937-46. PubMed ID: 12437309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
